Protocol No
BMS-CA0561060
Phase
III
Summary
This project is being done to learn more about Luspatercept if administrated at the maximum approved starting dose to assess that a quicker benefit can be seen in your transfusion burden and hemoglobin level.
Description
This project is being done to learn more about Luspatercept if administrated at the maximum approved starting dose to assess that a quicker benefit can be seen in your transfusion burden and hemoglobin level.
Status
SRC APPROVAL
Categories
ClinicalTrials.gov